| pubmed-article:18661379 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18661379 | lifeskim:mentions | umls-concept:C0040300 | lld:lifeskim |
| pubmed-article:18661379 | lifeskim:mentions | umls-concept:C0026809 | lld:lifeskim |
| pubmed-article:18661379 | lifeskim:mentions | umls-concept:C0600688 | lld:lifeskim |
| pubmed-article:18661379 | lifeskim:mentions | umls-concept:C0015020 | lld:lifeskim |
| pubmed-article:18661379 | lifeskim:mentions | umls-concept:C0017011 | lld:lifeskim |
| pubmed-article:18661379 | lifeskim:mentions | umls-concept:C0021149 | lld:lifeskim |
| pubmed-article:18661379 | lifeskim:mentions | umls-concept:C0332293 | lld:lifeskim |
| pubmed-article:18661379 | pubmed:issue | 8 | lld:pubmed |
| pubmed-article:18661379 | pubmed:dateCreated | 2008-7-28 | lld:pubmed |
| pubmed-article:18661379 | pubmed:abstractText | To determine the effects of Amifostine or WR-151,327 on the incidence of lethal and non-lethal toxicities in a large cohort of mice exposed to gamma-ray or fission-spectrum neutron radiation. | lld:pubmed |
| pubmed-article:18661379 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18661379 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18661379 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18661379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18661379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18661379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18661379 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18661379 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18661379 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:18661379 | pubmed:issn | 0955-3002 | lld:pubmed |
| pubmed-article:18661379 | pubmed:author | pubmed-author:GrdinaDavid... | lld:pubmed |
| pubmed-article:18661379 | pubmed:author | pubmed-author:KataokaYasush... | lld:pubmed |
| pubmed-article:18661379 | pubmed:author | pubmed-author:WoloschakGayl... | lld:pubmed |
| pubmed-article:18661379 | pubmed:author | pubmed-author:PauneskuTatja... | lld:pubmed |
| pubmed-article:18661379 | pubmed:author | pubmed-author:PauneskuDavid... | lld:pubmed |
| pubmed-article:18661379 | pubmed:author | pubmed-author:WahlAndrewA | lld:pubmed |
| pubmed-article:18661379 | pubmed:author | pubmed-author:MurleyJeffrey... | lld:pubmed |
| pubmed-article:18661379 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18661379 | pubmed:volume | 84 | lld:pubmed |
| pubmed-article:18661379 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18661379 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18661379 | pubmed:pagination | 623-34 | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:meshHeading | pubmed-meshheading:18661379... | lld:pubmed |
| pubmed-article:18661379 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18661379 | pubmed:articleTitle | Incidence of tissue toxicities in gamma ray and fission neutron-exposed mice treated with Amifostine. | lld:pubmed |
| pubmed-article:18661379 | pubmed:affiliation | Department of Radiation Oncology, University of Chicago, Chicago, Illinois, USA. | lld:pubmed |
| pubmed-article:18661379 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18661379 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
